Michael L. Scharf
Expertise in
16
conditions

Dr. Michael L. Scharf

Intensive Care Medicine
1101 Chestnut Street, Floor 17, 
Philadelphia, PA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
16
conditions
1101 Chestnut Street, Floor 17, 
Philadelphia, PA 

Overview

Michael Scharf is an Intensive Care Medicine provider practicing medicine in Philadelphia, Pennsylvania.

Dr. Scharf is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, Lung Metastases, and Vertebroplasty.

Dr. Scharf is board certified in Pulmonary Disease, Internal Medicine, and Critical Care Medicine. He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 5 clinical trials. Dr. Scharf is currently accepting new patients.

Graduate Institution

New York Medical College

Residency

Montefiore Medical Center

Specialties

Intensive Care Medicine

Licenses

Internal Medicine in NJ

Board Certifications

Pulmonary Disease
Internal Medicine
Critical Care Medicine

Fellowships

Temple University Hospital
Hospital of the University of Pennsylvania

Hospital Affiliations

Thomas Jefferson University Hospital

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Jane & Leonard Korman Respiratory Institute - Honickman Center
1101 Chestnut Street, Floor 17, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Scharf has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypersensitivity Pneumonitis
Cirrhosis

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2024
Intervention Type: Drug
Study Drug: AV-101
Study Phase: Phase 2/Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

8 Total Publications

Use of Latex Pulmonary Artery Catheters in Patients With a History of Cutaneous Latex Hypersensitivity: A Single-Center Retrospective Cohort Study.
Use of Latex Pulmonary Artery Catheters in Patients With a History of Cutaneous Latex Hypersensitivity: A Single-Center Retrospective Cohort Study.
Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: January 31, 2026
Similar Doctors
Expertise in
33
conditions
Dr. Gerard Criner
Intensive Care Medicine
Expertise in
33
conditions
Dr. Gerard Criner
Intensive Care Medicine
Referral may be required

Temple University Hospital

3401 N Broad St, 
Philadelphia, PA 
 (4.0 miles away)
215-707-1722
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gerard Criner is an Intensive Care Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Criner is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bronchitis, Lung Transplant, and Embolectomy.

Expertise in
15
conditions
Dr. Francis Cordova
Intensive Care Medicine
Expertise in
15
conditions
Dr. Francis Cordova
Intensive Care Medicine
Referral may be required

Main Line Healthcare Oaks

450 Cresson Blvd, 
Phoenixville, PA 
 (20.1 miles away)
610-630-2222
Languages Spoken:
English
See accepted insurances

Francis Cordova is an Intensive Care Medicine provider practicing medicine in Phoenixville, Pennsylvania. Dr. Cordova is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Gastrostomy.

Expertise in
10
conditions
Dr. Ross S. Summer
Intensive Care Medicine
Expertise in
10
conditions
Dr. Ross S. Summer
Intensive Care Medicine
Referral may be required

Jane & Leonard Korman Respiratory Institute - Honickman Center

1101 Chestnut Street, Floor 17, 
Philadelphia, PA 
 (0.3 miles away)
215-955-5161
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ross Summer is an Intensive Care Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Summer is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Idiopathic Pulmonary Fibrosis. Dr. Summer is board certified in Pulmonary Disease and Critical Care Medicine. Dr. Summer is currently accepting new patients.

Frequently Asked Questions about Dr. Michael L. Scharf

How do I make an appointment with Dr. Michael L. Scharf?

You can book an appointment with Dr. Michael L. Scharf by calling their office at 215-955-5161. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael L. Scharf a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael L. Scharf is classified as an Distinguished expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael L. Scharf specialize in?

While Dr. Michael L. Scharf is a Intensive Care Medicine, they have specific expertise in Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, and Acute Interstitial Pneumonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.

Does Dr. Michael L. Scharf participate in research or clinical trials?

Yes. Dr. Michael L. Scharf has published 8 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Michael L. Scharf's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael L. Scharf accept my insurance?

Dr. Michael L. Scharf accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 215-955-5161 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Scharf's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 8 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile